1. Dr Alan Johnson Clinical Scientist HPA Editor-in-Chief, JAC

2. Journal of Antimicrobial Chemotherapy Education Income generation

3. JAC Educational Remit Disseminate information Basic science Clinical Enhance the evidence base Clinical trials Systematic review Improve patient care

4. Income Generation Society journal for the British Society for Antimicrobial Chemotherapy Very active society Symposia Workshops Working parties Expert advice Income generation from journal essential for viability of the Society

5. Income Generation Subscriptions Reprints Supplements Advertising JAC needs to be “attractive” to readers, researchers, academia & pharma

6. Income Generation Most papers not open access (can be purchased) Papers free after 1 yr Only change to open access if business case shows income generation for BSAC would be protected

7. Issues Relating to Data Sharing Popular with authors? Patient confidentiality (case reports etc) Clinical trials sponsored by pharma Registries of treatment practice maintained by pharma

8. Surveillance of AMR Data supplied by hospitals Patient confidentiality Small cell size - deductive disclosure ONS guidelines: <5 cases No agreement for sharing of hospital data with third-parties Interpretation: Shared data misinterpreted